Comments

Lineage Cell Therapeutics

LCTXAMEX
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.948100
0.066.28%
At Close: -
15 minutes delayed
Lineage Cell Therapeutics (LCTX) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Lineage Cell Therapeutics (AMEX:LCTX) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Lineage Cell Therapeutics (LCTX)?

A

There have been no specific sales or earnings guidance reported for Lineage Cell Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch